Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-06-003285
Filing Date
2006-03-16
Accepted
2006-03-16 16:59:15
Documents
19
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y18060e10vk.htm 10-K 1474701
2 EX-10.8: AMENDED AND RESTATED STOCK INCENTIVE PLAN y18060exv10w8.txt EX-10.8 37392
3 EX-10.32: COMPENSATORY ARRANGEMENTS OF EXECUTIVE OFFICERS y18060exv10w32.txt EX-10.32 6221
4 EX-10.50: COMMITMENT LETTER y18060exv10w50.txt EX-10.50 24212
5 EX-10.51: LICENSE AGREEMENT y18060exv10w51.txt EX-10.51 200226
6 EX-10.52: COLLABORATION AGREEMENT y18060exv10w52.txt EX-10.52 241189
7 EX-10.53: LICENSE AGREEMENT y18060exv10w53.txt EX-10.53 128303
8 EX-10.54: LICENSE, MANUFACTURING AND SUPPLY AGREEMENT y18060exv10w54.txt EX-10.54 98599
9 EX-10.55: LETTER OF UNDERSTANDING y18060exv10w55.txt EX-10.55 11343
10 EX-10.56: MANUFACTURING AND SUPPLY AGREEMENT y18060exv10w56.txt EX-10.56 71696
11 EX-10.57: LICENSE AGREEMENT y18060exv10w57.txt EX-10.57 20873
12 EX-10.58: MANUFACTURING AND SUPPLY AGREEMENT y18060exv10w58.txt EX-10.58 161839
13 EX-10.59: SUMMARY OF INTERIM RETAINER FEE FOR NON-EMPLOYEE DIRECTORS y18060exv10w59.txt EX-10.59 2401
14 EX-21: SUBSIDIARIES OF OSI PHARMACEUTICALS, INC. y18060exv21.txt EX-21 522
15 EX-23: CONSENT OF KPMG LLP y18060exv23.txt EX-23 2169
16 EX-31.1: CERTIFICATION y18060exv31w1.htm EX-31.1 8044
17 EX-31.2: CERTIFICATION y18060exv31w2.htm EX-31.2 8129
18 EX-32.1: CERTIFICATION y18060exv32w1.htm EX-32.1 3648
19 EX-32.2: CERTIFICATION y18060exv32w2.htm EX-32.2 3756
  Complete submission text file 0000950123-06-003285.txt   2507516
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 06692708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances